Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hynes

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 1998
Progress in reducing anticipatory nausea and vomiting: a study of community practiceG R Morrow, J A Roscoe, H E Hynes, et al.
Molecular and Cellular Biology|August 1, 1990
Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cellsN E Hynes, D Taverna, I M Harwerth, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2013
Loss of Memo, a novel FGFR regulator, results in reduced lifespanBarbara Haenzi, Olivier Bonny, Régis Masson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockadePatrizia Sini, Lorenza Wyder, Christian Schnell, et al.
Nature|February 18, 1982
Long terminal repeats of endogenous mouse mammary tumour virus contain a long open reading frame which extends into adjacent sequencesN Kennedy, G Knedlitschek, B Groner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factorsL N Klapper, S Glathe, N Vaisman, et al.
Molecular and Cellular Biology|April 11, 2000
ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependencyH A Lane, I Beuvink, A B Motoyama, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
The EMBO Journal|January 1, 1988
Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequencesS C Kozma, S M Redmond, X C Fu, et al.
Cancer Research|September 1, 1997
Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cellsJ M Daly, C B Jannot, R R Beerli, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 1998
Progress in reducing anticipatory nausea and vomiting: a study of community practiceG R Morrow, J A Roscoe, H E Hynes, et al.
Molecular and Cellular Biology|August 1, 1990
Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cellsN E Hynes, D Taverna, I M Harwerth, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2013
Loss of Memo, a novel FGFR regulator, results in reduced lifespanBarbara Haenzi, Olivier Bonny, Régis Masson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockadePatrizia Sini, Lorenza Wyder, Christian Schnell, et al.
Nature|February 18, 1982
Long terminal repeats of endogenous mouse mammary tumour virus contain a long open reading frame which extends into adjacent sequencesN Kennedy, G Knedlitschek, B Groner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factorsL N Klapper, S Glathe, N Vaisman, et al.
Molecular and Cellular Biology|April 11, 2000
ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependencyH A Lane, I Beuvink, A B Motoyama, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
The EMBO Journal|January 1, 1988
Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequencesS C Kozma, S M Redmond, X C Fu, et al.
Cancer Research|September 1, 1997
Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cellsJ M Daly, C B Jannot, R R Beerli, et al.
Pageof 28